Lista de obras -

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.

artículo científico publicado en 2009

A Phase II Clinical Trial of Topotecan in Japanese Patients with Relapsed Ovarian Carcinoma ⬇️

artículo científico publicado el 25 de octubre de 2010

A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer ⬇️

artículo científico publicado el 11 de octubre de 2010

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer

artículo científico publicado en 2003

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

artículo científico publicado en 2012

A phase I study and pharmacologic evaluation of irinotecan and carboplatin for patients with advanced ovarian carcinoma who previously received platinum-containing chemotherapy

artículo científico publicado en 2005

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

artículo científico publicado en 2014

A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505).

artículo científico publicado en 2009

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer

artículo científico publicado en 2013

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

artículo científico publicado en 2010

An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients

artículo científico publicado en 2006

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

scientific article published on 01 February 2008

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed

artículo científico publicado en 2008

Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey

artículo científico publicado en 2015

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2009

Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan

artículo científico publicado en 2006

Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial

scientific article published on 01 September 2004

Clinical efficacy of S-1 in pretreated metastatic breast cancer patients

artículo científico publicado en 2008

Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy

artículo científico publicado en 2012

Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer

artículo científico publicado en 2009

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

artículo científico publicado en 2008

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

artículo científico publicado en 2006

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer

artículo científico publicado en 2007

Development and preliminary evaluation of communication skills training program for oncologists based on patient preferences for communicating bad news

artículo científico publicado en 2013

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer

artículo científico publicado en 2008

Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.

artículo científico publicado en 2005

Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer? Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial ⬇️

artículo científico publicado el 1 de diciembre de 2011

Dose-dense chemotherapy and neoadjuvant chemotherapy for ovarian cancer

artículo científico publicado en 2012

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

artículo científico publicado en 2009

Effect of communication skills training program for oncologists based on patient preferences for communication when receiving bad news: a randomized controlled trial

artículo científico publicado en 2014

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial

scientific article published on 03 September 2019

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

artículo científico publicado en 2005

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

artículo científico publicado en 2010

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

artículo científico

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death

artículo científico publicado en 2009

Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice

artículo científico publicado en 2010

Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

artículo científico publicado en 2004

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

artículo científico

Genetic testing for effective Herceptin therapy

artículo científico publicado en 2002

HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab.

artículo científico publicado en 2002

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

artículo científico publicado en 2009

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

artículo científico publicado en 2010

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

artículo científico publicado en 2008

Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer.

artículo científico publicado en 2012

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors

artículo científico publicado en 2010

Latest information of therapeutic approach for endometrial cancer

artículo científico publicado en 2002

Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate

artículo científico publicado en 2008

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label tr

scientific article published on 13 August 2013

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials

artículo científico publicado en 2013

Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.

artículo científico publicado en 2009

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.

artículo científico publicado en 2015

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

artículo científico publicado en 2011

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

artículo científico publicado en 2011

Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-base

artículo científico publicado en 2008

Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer

artículo científico publicado en 2003

Phase II study of oral etoposide and intravenous irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer: Japan Clinical Oncology Group Study 0503

artículo científico publicado en 2012

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

artículo científico publicado en 2014

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

artículo científico publicado en 2018

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

artículo científico publicado en 2006

Primary yolk sac tumor of the omentum: a case report and literature review

artículo científico publicado en 2012

Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.

artículo científico publicado en 2009

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

artículo científico publicado en 2009

Reliability of Cancer Treatment Information on the Internet: Observational Study

artículo científico publicado en 2018

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer

artículo científico publicado en 2010

Satisfying the needs of Japanese cancer patients: a comparative study of detailed and standard informed consent documents

artículo científico publicado en 2014

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

artículo científico publicado en 2010

Second-line chemotherapy in patients with primary unknown cancer.

artículo científico publicado en 2011

Serous adenocarcinoma of the retroperitoneum, as a type of multifocal müllerian carcinoma.

artículo científico publicado en 2009

Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan

artículo científico publicado en 2003

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

artículo científico publicado en 2010

The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study.

artículo científico publicado en 2015

The notorious "drug lag" for oncology drugs in Japan

scientific article published on February 2011

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

artículo científico publicado en 2006

The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer

artículo científico publicado en 2005

The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery

artículo científico publicado en 2004

Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer

artículo científico publicado en 2008

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

artículo científico publicado en 2011

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

scientific article published on 22 June 2006

Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel

artículo científico publicado en 2003

Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan

artículo científico publicado en 2014

Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma

artículo científico publicado en 2011

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

artículo científico publicado en 2008

Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.

artículo científico publicado en 2007

Weekly paclitaxel in patients with CAP-resistant advanced or recurrent endometrial carcinoma: a series of four patients.

artículo científico publicado en 2005

[A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]

artículo científico publicado en 2006

[Acute Hyperuricemia and Kidney Injury after Three Cycles of Dose-Dense Chemotherapy for Retroperitoneal Choriocarcinoma -- A Case Report]

[Guidelines for proper use of antineoplastic agents. Gynecologic cancer]

artículo científico publicado en 2002

Lista de obras de

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.

A Phase II Clinical Trial of Topotecan in Japanese Patients with Relapsed Ovarian Carcinoma ⬇️

A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer ⬇️

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

A phase I study and pharmacologic evaluation of irinotecan and carboplatin for patients with advanced ovarian carcinoma who previously received platinum-containing chemotherapy

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505).

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed

Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan

Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial

Clinical efficacy of S-1 in pretreated metastatic breast cancer patients

Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy

Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer

Development and preliminary evaluation of communication skills training program for oncologists based on patient preferences for communicating bad news

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer

Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.

Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer? Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial ⬇️

Dose-dense chemotherapy and neoadjuvant chemotherapy for ovarian cancer

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Effect of communication skills training program for oncologists based on patient preferences for communication when receiving bad news: a randomized controlled trial

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death

Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice

Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

Genetic testing for effective Herceptin therapy

HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab.

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer.

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors

Latest information of therapeutic approach for endometrial cancer

Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label tr

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials

Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-base

Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer

Phase II study of oral etoposide and intravenous irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer: Japan Clinical Oncology Group Study 0503

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

Primary yolk sac tumor of the omentum: a case report and literature review

Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

Reliability of Cancer Treatment Information on the Internet: Observational Study

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer

Satisfying the needs of Japanese cancer patients: a comparative study of detailed and standard informed consent documents

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

Second-line chemotherapy in patients with primary unknown cancer.

Serous adenocarcinoma of the retroperitoneum, as a type of multifocal müllerian carcinoma.

Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study.

The notorious "drug lag" for oncology drugs in Japan

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer

The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery

Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel